Literature DB >> 30661951

Imprecise Spacer Acquisition Generates CRISPR-Cas Immune Diversity through Primed Adaptation.

Simon A Jackson1, Nils Birkholz2, Lucía M Malone2, Peter C Fineran3.   

Abstract

Many prokaryotes possess CRISPR-Cas adaptive immune systems to defend against viruses and invading mobile genetic elements. CRISPR-Cas immunity relies on genetic memories, termed spacers, for sequence-specific recognition of infections. The diversity of spacers within host populations is important for immune resilience, but we have limited understanding of how CRISPR diversity is generated. Type I CRISPR-Cas systems use existing spacers to enhance the acquisition of new spacers through primed CRISPR adaptation (priming). Here, we present a pathway to priming that is stimulated by imprecisely acquired (slipped) spacers. Slipped spacers are less effective for immunity but increase priming compared with canonical spacers. The benefits of slipping depend on the relative rates of phage mutation and adaptation during defense. We propose that slipped spacers provide a route to increase population-level spacer diversity that pre-empts phage escape mutant proliferation and that the trade-off between adaptation and immunity is important in diverse CRISPR-Cas systems.
Copyright © 2019 Elsevier Inc. All rights reserved.

Keywords:  CRISPR-Cas; adaptation; coevolution; diversity; phage; primed; priming; slipping; spacer acquisition

Mesh:

Substances:

Year:  2019        PMID: 30661951     DOI: 10.1016/j.chom.2018.12.014

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  15 in total

1.  The Rcs stress response inversely controls surface and CRISPR-Cas adaptive immunity to discriminate plasmids and phages.

Authors:  Leah M Smith; Simon A Jackson; Lucia M Malone; James E Ussher; Paul P Gardner; Peter C Fineran
Journal:  Nat Microbiol       Date:  2021-01-04       Impact factor: 17.745

2.  A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.

Authors:  Lucia M Malone; Suzanne L Warring; Simon A Jackson; Carolin Warnecke; Paul P Gardner; Laura F Gumy; Peter C Fineran
Journal:  Nat Microbiol       Date:  2019-12-09       Impact factor: 17.745

3.  Fidelity of prespacer capture and processing is governed by the PAM-mediated interactions of Cas1-2 adaptation complex in CRISPR-Cas type I-E system.

Authors:  Kakimani Nagarajan Yoganand; Manasasri Muralidharan; Siddharth Nimkar; Baskaran Anand
Journal:  J Biol Chem       Date:  2019-11-20       Impact factor: 5.157

Review 4.  Creating memories: molecular mechanisms of CRISPR adaptation.

Authors:  Hayun Lee; Dipali G Sashital
Journal:  Trends Biochem Sci       Date:  2022-02-28       Impact factor: 14.264

Review 5.  The arms race between bacteria and their phage foes.

Authors:  Hannah G Hampton; Bridget N J Watson; Peter C Fineran
Journal:  Nature       Date:  2020-01-15       Impact factor: 49.962

6.  Long-run bacteria-phage coexistence dynamics under natural habitat conditions in an environmental biotechnology system.

Authors:  Leandro D Guerrero; María V Pérez; Esteban Orellana; Mariana Piuri; Cecilia Quiroga; Leonardo Erijman
Journal:  ISME J       Date:  2020-10-16       Impact factor: 10.302

7.  Systematic analysis of Type I-E Escherichia coli CRISPR-Cas PAM sequences ability to promote interference and primed adaptation.

Authors:  Olga Musharova; Vasily Sitnik; Marnix Vlot; Ekaterina Savitskaya; Kirill A Datsenko; Andrey Krivoy; Ivan Fedorov; Ekaterina Semenova; Stan J J Brouns; Konstantin Severinov
Journal:  Mol Microbiol       Date:  2019-04-06       Impact factor: 3.501

8.  The autoregulator Aca2 mediates anti-CRISPR repression.

Authors:  Nils Birkholz; Robert D Fagerlund; Leah M Smith; Simon A Jackson; Peter C Fineran
Journal:  Nucleic Acids Res       Date:  2019-10-10       Impact factor: 16.971

Review 9.  Detection of CRISPR adaptation.

Authors:  Anna Shiriaeva; Ivan Fedorov; Danylo Vyhovskyi; Konstantin Severinov
Journal:  Biochem Soc Trans       Date:  2020-02-28       Impact factor: 5.407

10.  Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity.

Authors:  Bridget N J Watson; Reuben B Vercoe; George P C Salmond; Edze R Westra; Raymond H J Staals; Peter C Fineran
Journal:  Nat Commun       Date:  2019-12-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.